Announcements

Job offersmore »



Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




CAN (QC): Planning underway for new Quebec cannabis project

MYM Nutraceuticals announces that GGS Structures and CannaCanada, subsidiary of MYM, are working together on the planning and design of the 1.5 million sq. ft. Weedon Cannabis Greenhouse Production Project.

Gerry Harrison of GGS Structures commented, "We are thrilled to be working with MYM Nutraceuticals on their project located at Weedon, Quebec. Planning is underway for the first phase of a greenhouse medical cannabis cultivation facility of approximately 100,000 sf. The completed state of the art growing facility will consist of 15 greenhouses that will total 1,500,000 sq. sf."

Weedon Health Canada commercial cannabis production license application has been submitted. MYM's consultants Factotum Consultants, who have successfully obtained Licensed Producer licenses for other clients, are managing the ACMPR application process and have submitted the Weedon application to Health Canada on June 28, 2017.

Weedon quality assurance position filled
David O'Halloran, BSc. has joined the MYM/CanaCanada team as the Quality Assurance Person for the Weedon Project. David O'Halloran brings sixteen years of Quality Assurance and Regulatory Affairs experience to the team. Having graduated from the Cork Institute of Technology in Ireland with a Bachelor of Science in Pharmaceutical Chemistry, David spent five years working in the laboratories of Novartis in the south Coast of Ireland. In 2006, he immigrated to Canada where he began working for PharmAthene Canada Inc., the Canadian division of an American biotech company contracted by the US Department of Defense to develop countermeasures for chemical and biological warfare. Following that he spent two years as Quality Assurance and Regulatory Affairs Director with Vivier Pharma.

David has since been consulting for companies to obtain their licenses from Health Canada, first under the Marihuana for Medical Purposes Regulations (MMPR), and later, the Access to Cannabis for Medical Purposes Regulations (AMPR), submitting applications on behalf of the companies, setting up quality management systems and helping in the design of production facilities to ensure optimal production efficiency and regulatory compliance.

For more information:
MYM Nutraceuticals
1-855-696-2261
info@mymarijuana.ca
www.mymarijuana.ca


GGS Structures
ggs-greenhouse.com

Publication date: 6/30/2017

 


 

Other news in this sector:

4/23/2018 Another cannabis investment for Scotts Miracle-Gro
4/23/2018 Canada: Researcher warns cannabis bubble might burst
4/20/2018 US (NM): Cannabis provider unveils 8.7 million sq.ft. facility
4/20/2018 The great cannabis switcheroo
4/19/2018 Canada: MPX to acquire MMJ producer Canveda
4/18/2018 US (NV): Marapharm's Las Vegas sites get green light to flip the switch
4/18/2018 CAN (ON): MedReleaf completes 1 million sq.ft. greenhouse acquisition
4/17/2018 CAN (BC): BC Tweed adds licensed growing space
4/17/2018 New cannabis strain to be named after Meghan Markle
4/16/2018 US: Trump, Gardner strike deal on legalized marijuana
4/13/2018 Malta: Australian firm to build 4,000 m2 MMJ facility
4/12/2018 US: Former Republican Speaker of the House joins cannabis firm
4/12/2018 Canada: Québec orders tons of cannabis from six growers
4/12/2018 US: Fluence shines light on state-of-the-art cannabis greenhouse
4/11/2018 US (CA): Cannabis company receives $1M insurance payout following fire
4/10/2018 Canada: Canopy to help LiveWell develop cannabis greenhouses
4/9/2018 Italian firm files patent for solar powered cannabis and cryptocurrency farm
4/6/2018 Canada: Marijuana millionaires riding legalization wave
4/6/2018 CAN (ON): First harvest from Aphria expansion expected end of April
4/5/2018 LED Grower's Guide for Cannabis